Price loading...

The 2023-2028 Outlook for Schizophrenia Treatments in Japan

Price data last checked 109 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 November 2022
Listed Since
08 December 2022

Similar Products You Might Like

The 2023-2028 Outlook for Schizophrenia Therapeutics in Japan
99% match

The 2023-2028 Outlook for Schizophrenia Therapeutics in Japan

£495.00 18 Mar 2026
The 2023-2028 Outlook for Schizophrenia Drugs in Japan
99% match

The 2023-2028 Outlook for Schizophrenia Drugs in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in Japan
98% match

The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for First Generation Antipsychotic Drugs for Schizophrenia in Japan
98% match

The 2023-2028 Outlook for First Generation Antipsychotic Drugs for Schizophrenia in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Alzheimer's Treatments in Japan
96% match

The 2023-2028 Outlook for Alzheimer's Treatments in Japan

£495.00 16 Dec 2025
The 2023-2028 Outlook for Sarcopenia Treatments in Japan
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in Japan

£495.00 08 Jan 2026
The 2023-2028 Outlook for Stress Management Treatments in Japan
96% match

The 2023-2028 Outlook for Stress Management Treatments in Japan

£495.00 11 Feb 2026
The 2023-2028 Outlook for Insomnia Therapeutics in Japan
96% match

The 2023-2028 Outlook for Insomnia Therapeutics in Japan

£495.00 11 Jan 2026
The 2023-2028 Outlook for Personal Therapy Products in Japan
96% match

The 2023-2028 Outlook for Personal Therapy Products in Japan

£495.00 14 Jan 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan

£495.00 06 Feb 2026
The 2023-2028 Outlook for Motion Sickness Treatments in Japan
96% match

The 2023-2028 Outlook for Motion Sickness Treatments in Japan

£495.00 11 Mar 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in Japan
96% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in Japan
96% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in Japan
96% match

The 2023-2028 Outlook for Myopia and Presbyopia Treatments in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan
96% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan

£495.00 05 Feb 2026
The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in Japan
96% match

The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in Japan

£495.00 11 Jan 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in Japan
96% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in Japan

£495.00 24 Jan 2026
The 2023-2028 Outlook for Atopic Dermatitis Treatments in Japan
96% match

The 2023-2028 Outlook for Atopic Dermatitis Treatments in Japan

£495.00 11 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan

£495.00 09 Jan 2026
The 2023-2028 Outlook for Vitiligo Treatments in Japan
96% match

The 2023-2028 Outlook for Vitiligo Treatments in Japan

£495.00 03 Apr 2026
The 2023-2028 Outlook for Respiratory Disorder Treatments in Japan
95% match

The 2023-2028 Outlook for Respiratory Disorder Treatments in Japan

£495.00 07 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in Japan
95% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Macular Degeneration Treatments in Japan
95% match

The 2023-2028 Outlook for Macular Degeneration Treatments in Japan

£495.00 13 Dec 2025
The 2023-2028 Outlook for Diabetic Retinopathy Treatments in Japan
95% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in Japan

£495.00 13 Jan 2026